[Trial at the guidance center of ixelles of a major neuroleptic drug: anatensol decanoate]
- PMID: 4455024
[Trial at the guidance center of ixelles of a major neuroleptic drug: anatensol decanoate]
Similar articles
-
[Results of the use of fluphenazine in a depot preparation].Psychiatr Neurol Med Psychol Beih. 1975;20-21:176-82. Psychiatr Neurol Med Psychol Beih. 1975. PMID: 829619 French.
-
[Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].Ann Med Psychol (Paris). 1972 Feb;1(2):277-83. Ann Med Psychol (Paris). 1972. PMID: 5051257 French. No abstract available.
-
[Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].Zh Nevropatol Psikhiatr Im S S Korsakova. 1973;73(5):753-8. Zh Nevropatol Psikhiatr Im S S Korsakova. 1973. PMID: 4718619 Russian. No abstract available.
-
The depot fluphenazines: a reappraisal after 10 years' clinical experience.Am J Psychiatry. 1975 May;132(5):491-500. doi: 10.1176/ajp.132.5.491. Am J Psychiatry. 1975. PMID: 1091162 Review. No abstract available.
-
Side effects of depot fluphenazines.Adv Biochem Psychopharmacol. 1974;9(0):301-9. Adv Biochem Psychopharmacol. 1974. PMID: 4599435 Review. No abstract available.
Cited by
-
Fluphenazine decanoate (depot) and enanthate for schizophrenia.Cochrane Database Syst Rev. 2015 Feb 5;2015(2):CD000307. doi: 10.1002/14651858.CD000307.pub2. Cochrane Database Syst Rev. 2015. PMID: 25654768 Free PMC article.